4.8 Article

PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation

期刊

CELL REPORTS
卷 13, 期 1, 页码 15-22

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2015.08.058

关键词

-

资金

  1. Karolinska Institutet (KID programme)
  2. Swedish Research Council
  3. Family Erling-Persson Foundation
  4. Novo Nordisk Foundation
  5. Stichting af Jochnick Foundation
  6. Swedish Diabetes Association
  7. Scandia Insurance Company Ltd.
  8. Diabetes Research and Wellness Foundation
  9. Berth von Kantzow's Foundation
  10. Strategic Research Program in Diabetes at Karolinska Institutet
  11. ERC-AdG [338936-BetaImage]
  12. Swedish Foundation for Strategic Research
  13. Knut and Alice Wallenberg Foundation
  14. JDRF [31-2008-416]
  15. Novo Nordisk Fonden [NNF12OC1016557] Funding Source: researchfish

向作者/读者索取更多资源

Insulin resistance is a syndrome that affects multiple insulin target tissues, each having different biological functions regulated by insulin. A remaining question is to mechanistically explain how an insulin target cell/tissue can be insulin resistant in one biological function and insulin sensitive in another at the same time. Here, we provide evidence that in pancreatic beta cells, knockdown of PI3K-C2 alpha expression results in rerouting of the insulin signal from insulin receptor (IR)-B/PI3K-C2 alpha/PKB-mediated metabolic signaling to IR-B/Shc/ERK-mediated mitogenic signaling, which allows the beta cell to switch from a highly glucose-responsive, differentiated state to a proliferative state. Our data suggest the existence of IR-cascade-selective insulin resistance, which allows rerouting of the insulin signal within the same target cell. Hence, factors involved in the rerouting of the insulin signal represent tentative therapeutic targets in the treatment of insulin resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据